Progenics Pharmaceuticals, Inc.

Apr 23, 2020

Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Progenics Pharmaceuticals, Inc. (PGNX)

Jul 08, 2019

Velan Reminds Stockholders to Follow ISS' Recommendation by Voting "Against" Progenics Pharmaceuticals Directors Peter Crowley and Michael Kishbauch

Jun 20, 2019

Velan Calls on Progenics Pharmaceuticals' Board to Back Up Recent Claims

Jun 11, 2019

Velan Capital Sends Letter to Stockholders Calling Out Progenics Pharmaceuticals' Board for Unnecessarily Diluting Stockholders to Support Outsized And Undeserved Compensation

May 13, 2019

Velan Implores for Improved Transparency and Real Change at Progenics Pharmaceuticals Following Q1 2019 Earnings Call

May 08, 2019

Velan Calls for Increased Transparency at Progenics Pharmaceuticals During Q1 Earnings Call

May 06, 2019

Velan Delivers Letter to the Board of Progenics Pharmaceuticals

Jul 30, 2018

FDA approves first treatment for rare adrenal tumors